Dr. Henri Xhaard is currently the head of the Computational Drug Discovery Group at the Centre for Drug Research, at the Faculty of Pharmacy, University of Helsinki. He completed MSc (Biophysics) at the University of Paris-VI, France and a PhD (Biochemistry) in molecular modeling in 2006 at the Åbo Akademi University, Finland. He also worked one year in the industry (Sanofi-Aventis, L’Oreal). He is expert in molecular modeling and computer-aided drug discovery. He has long experience working with G protein-coupled receptors as well as other membrane proteins such as transporters. He is member of the Management Committee for the COST Action CM1207 on GPCRs. The funding sources of the group are University of Helsinki Research Funds, foundations, and Biocenter Finland translational networks in Drug Discovery and Chemical Biology. He is currently supervising 6 PhD students and mentoring 2 postdoctoral researchers. Dr. Xhaard is author of 20 peer-reviewed articles including 2 book chapters.
Dr. Xhaard’s role in GLORIA is to conduct structure-based and ligand-based virtual screening; develope QSAR models to explain SARs and use molecular modeling to guide ligand design and optimisation.
University of Helsinki: Mikko Airavaara • Viljami Jokinen • Eija Kalso • Oleg Kambur • Leena Karhinen • Mari Kaunisto • Zhilin Li • Tuomas Lilius • Vânia Moreira • Kert Mätlik • Pekka Rauhala • Maiju Rinne • Mart Saarma • Yulia Sidorova • Ilida Sulemanyova • Li Tian • Jaakko Vartia • Hanna Viisanen-Kuopila • Henri Xhaard • Jari Yli-Kauhaluoma